140 related articles for article (PubMed ID: 26911608)
21. Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.
Watson WA; Rhodes NJ; Echenique IA; Angarone MP; Scheetz MH
J Clin Pharm Ther; 2017 Jun; 42(3):350-355. PubMed ID: 28370067
[TBL] [Abstract][Full Text] [Related]
22. Acyclovir in the treatment of infection due to herpes viruses.
Zicha J; Stafová J; Vacek V
Czech Med; 1986; 9(4):203-5. PubMed ID: 3028734
[TBL] [Abstract][Full Text] [Related]
23. Adverse reactions to acyclovir: topical, oral, and intravenous.
Arndt KA
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):188-90. PubMed ID: 3339141
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous adverse reactions to acyclovir: case reports.
Robinson GE; Weber J; Griffiths C; Underhill GS; Jeffries DJ; Goldmeir D
Genitourin Med; 1985 Feb; 61(1):62-3. PubMed ID: 2935482
[TBL] [Abstract][Full Text] [Related]
25. Valacyclovir-induced urticaria without acyclovir hypersensitivity.
Singh SK; Prabhu A; Kumar A
Indian J Dermatol Venereol Leprol; 2015; 81(6):611-2. PubMed ID: 26515842
[No Abstract] [Full Text] [Related]
26. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
27. Neurotoxic side effects of acyclovir: two case reports.
Paluch Z; Trojánek M; Velíšková Z; Mlíchová J; Chrbolka P; Gregorová J; Marques E; Kalatova D; Pícha D
Neuro Endocrinol Lett; 2021 Oct; 42(6):375-382. PubMed ID: 34713692
[TBL] [Abstract][Full Text] [Related]
28. Lichen Planus Possibly Induced by Acyclovir in a Child.
Alani A; Sadlier M; Ahmad K
Acta Derm Venereol; 2016 Feb; 96(2):266-7. PubMed ID: 26122539
[No Abstract] [Full Text] [Related]
29. Painless acyclovir extravasation injury in a diabetic.
De Souza BA; Shibu M
Br J Plast Surg; 2002 Apr; 55(3):264. PubMed ID: 12041990
[No Abstract] [Full Text] [Related]
30. Emergent hemodialysis for acyclovir toxicity.
Hsu CC; Lai TI; Lien WC; Chen WJ; Fang CC
Am J Emerg Med; 2005 Nov; 23(7):899-900. PubMed ID: 16291450
[No Abstract] [Full Text] [Related]
31. Systemic side effects of antiviral therapy in a patient with acute retinal necrosis.
Guney E; Akcay BI; Erdogan G; Unlu C; Bozkurt K; Onur U
Ocul Immunol Inflamm; 2014 Jun; 22(3):233-5. PubMed ID: 24063786
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir- and ganciclovir-induced neurotoxicity.
Ernst ME; Franey RJ
Ann Pharmacother; 1998 Jan; 32(1):111-3. PubMed ID: 9475829
[TBL] [Abstract][Full Text] [Related]
33. Risk of acute kidney injury from oral acyclovir: a population-based study.
Lam NN; Weir MA; Yao Z; Blake PG; Beyea MM; Gomes T; Gandhi S; Mamdani M; Wald R; Parikh CR; Hackam DG; Garg AX
Am J Kidney Dis; 2013 May; 61(5):723-9. PubMed ID: 23312723
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
[TBL] [Abstract][Full Text] [Related]
35. [Possibilities and limits of chemotherapy of diseases caused by herpes simplex and varicella-zoster virus].
Wassilew SW
Hautarzt; 1983 Jan; 34(1):1-5. PubMed ID: 6841073
[TBL] [Abstract][Full Text] [Related]
36. Herpes zoster oticus: treatment with intravenous acyclovir.
Dickins JR; Smith JT; Graham SS
Laryngoscope; 1988 Jul; 98(7):776-9. PubMed ID: 3386386
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.
Ljungman P; Lönnqvist B; Ringdén O; Skinhöj P; Gahrton G
Bone Marrow Transplant; 1989 Nov; 4(6):613-5. PubMed ID: 2684306
[TBL] [Abstract][Full Text] [Related]
38. Hemodialysis removal of acyclovir.
Leikin JB; Shicker L; Orlowski J; Blair AT; McAllister K
Vet Hum Toxicol; 1995 Jun; 37(3):233-4. PubMed ID: 7571352
[TBL] [Abstract][Full Text] [Related]
39. Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.
Hoskote SS; Annapureddy N; Ramesh AK; Rose K; Jones JP
Am J Ther; 2016; 23(1):e304-6. PubMed ID: 24368610
[TBL] [Abstract][Full Text] [Related]
40. A nonscarring sublamina densa bullous drug eruption.
Roholt NS; Lapiere JC; Traczyk T; Chan LS; Woodley DT
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):367-71. PubMed ID: 7829742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
